Microtuble-associated protein 2 (MAP2) is a protein that plays a crucial role in the regulation of microtubule dynamics and interactions, essential in neurogenesis. Biosensis’s validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.
The company’s antibodies for MAP2 variants include antibodies that specifically target MAP2a and MAP2b, demonstrating high performance in western blots, as well as antibodies that identify all four MAP2 variants. They are distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
ProSci Incorporated apoptosis antibodies
ProSci Incorporated provides an extensive catalogue of apoptotic antibodies including death...
TdB Labs polysaccharides
TdB Labs' polysaccharide portfolio consists of both fluorescent and non-fluorescent...
Cayman Chemical Epigenetics Screening Library (96-Well)
The Cayman Chemical Epigenetics Screening Library (96-Well) is a compound library that is...
